Home/Filings/4/0001019056-17-000286
4//SEC Filing

Aptevo Therapeutics Inc. 4

Accession 0001019056-17-000286

$APVOCIK 0001671584operating

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 9:05 PM ET

Size

19.2 KB

Accession

0001019056-17-000286

Insider Transaction Report

Form 4
Period: 2017-03-01
Stromatt Scott C
Chief Medical Officer and SVP
Transactions
  • Exercise/Conversion

    Common Stock

    2017-03-09+13,90254,484 total
  • Tax Payment

    Common Stock

    2017-03-10$1.78/sh6,570$11,69569,072 total
  • Exercise/Conversion

    Restricted Stock Unit

    2017-03-0116,269190,672 total
    Common Stock (16,269 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2017-03-0913,902176,770 total
    Common Stock (13,902 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2017-03-1024,836151,934 total
    Common Stock (24,836 underlying)
  • Exercise/Conversion

    Common Stock

    2017-03-01+16,26945,894 total
  • Tax Payment

    Common Stock

    2017-03-09$1.80/sh3,678$6,62050,806 total
  • Tax Payment

    Common Stock

    2017-03-01$2.02/sh5,312$10,73040,582 total
  • Exercise/Conversion

    Common Stock

    2017-03-10+24,83675,642 total
Footnotes (4)
  • [F1]Each RSU converts into the Issuer's common stock on a one-for-one basis.
  • [F2]The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vest in three equal annual installments on the anniversary of the grant date.
  • [F3]The RSUs were originally issued by Emergent on March 10, 2015 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs vest as follows: 13,902 on March 9, 2017 and 13,892 on March 9, 2018.
  • [F4]The RSUs were originally issued by Emergent on March 11, 2014 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs fully vested on March 10, 2017.

Issuer

Aptevo Therapeutics Inc.

CIK 0001671584

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001671584

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 9:05 PM ET
Size
19.2 KB